Post coronavirus disease mucormycosis involving the mandible

Abstract

Mucormycosis also termed as phycomycosis or zygomycosis is less commonly seen in oral cavity. However, it is an invasive, life-threatening and aggressive fungal infection. It mostly targets individuals with altered immunological system and diabetes. In this recent pandemic situation, the individuals affected with coronavirus disease 2019 (COVID-19) are also affected with this fungal infection which commonly involves the maxilla. In this case report, we present a case of a 45-year-old female affected with mucormycosis in post-COVID scenario involving mandible which is quite rare situation. The case report covers clinical findings, radiographic investigations and histopathological details with brief on literature review. Since mucormycosis is aggressive fungal infection, it should be handled with multimodal approach to reduce the systemic damage of an individual, morbidity and mortality.

Untitled

“…There are only a few isolated case reports of Covid-19 associated mandibular mucormycosis in the literature. 23,24 How mucorales gain access to mandible is not clear as it is not contiguous with para nasal sinuses. The portal of entry is probably due to direct inoculation during dental procedures or minor dental trauma.…”

“…Our cases are more homogenous and all had previous Covid-19 with steroid use followed by diabetes (Table 1). [6][7][8][9][10][11][12][13][14][15][16][17][18][19][20][21][22][23] Citation: Dipankar…”

“…Mandibular mucormycosis: reports in literature[6][7][8][9][10][11][12][13][14][15][16][17][18][19][20][21][22][23] …”